Myocardial Revascularization Clinical Trial
Official title:
Effects of Continuous Positive Airway Pressure (CPAP)and Physical Exercise on Cycle Ergometer in Myocardial Revascularization Post-surgical Patients
Verified date | September 2021 |
Source | Riphah International University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim is to evaluate the effectiveness of physical exercise on a cycle ergometer combine with CPAP in the postoperative period after myocardial revascularization
Status | Completed |
Enrollment | 102 |
Est. completion date | August 20, 2021 |
Est. primary completion date | August 20, 2021 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years to 75 Years |
Eligibility | Inclusion Criteria: - Subjects who have undergone myocardial revascularization surgery - An ejection fraction of greater than40% - Post operative mechanical ventilation for <12hours - No definite diagnosis of chronic obstructive pulmonary disease and asthma Exclusion Criteria: - With complications in post operative period (e.g., Artial fibrillation, prolonged mechanical ventilation) - Hemodynamically unstable patients - Intolerance to CPAP(continuous positive airway)mask |
Country | Name | City | State |
---|---|---|---|
Pakistan | Rawalpindi institute of cardiology | Rawalpindi | Punjab |
Lead Sponsor | Collaborator |
---|---|
Riphah International University |
Pakistan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Modified Borg scale | The Modified Borg Dyspnoea Scale is most commonly used to assess symptoms of breathlessness. Despite being a subjective measure of exercise intensity, RPE scales provide valuable information when used correctly. | 4th day | |
Primary | 6 min walk distance | The six minute walking test (6MWT) was developed by the American Thoracic Society and it was officially introduced in 2002, coming along with a comprehensive guideline. The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity | 4th day | |
Primary | 1 min sit to stand test | Vaidya et al reported that 1-minute STS test is a simple and sensitive test and appears to be a practical, reliable, valid, and responsive alternative for measuring exercise capacity, particularly where space and time are limited | 4th day | |
Primary | Digital Monovacumeter | The manovacuometer is a simple, quick and non-invasive test which measures the maximal respiratory pressures (MRS).Digital manovacuometer is a reliable and valid instrument for assessing maximum inspiratory pressure and maximum expiratory pressure in healthy subjects | 4th day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02840006 -
Spinal Anesthesia Associated With General Anesthesia in Coronary Artery Bypass
|
Phase 4 | |
Completed |
NCT05466825 -
Global Cardiovascular Risk Consortium
|
||
Recruiting |
NCT04591938 -
FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study
|
N/A | |
Completed |
NCT01841944 -
Omega-3 Fatty Acids in Elderly Patients With Acute Myocardial Infarction
|
N/A | |
Recruiting |
NCT03562572 -
FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease
|
N/A | |
Recruiting |
NCT00755248 -
Coronary Artery Bypass Grafting: Factors Related to Late Events and Saphenous Graft Patency
|
N/A | |
Not yet recruiting |
NCT00388245 -
Revascularization in Heart Failure Trial – REHEAT 2
|
Phase 4 | |
Completed |
NCT00375063 -
Study of Unprotected Left Main Stenting Versus Bypass Surgery (LE MANS Study)
|
Phase 4 | |
Completed |
NCT02580851 -
Magnetic Resonance Adenosine Perfusion Imaging as Gatekeeper of Invasive Coronary Intervention
|
N/A | |
Recruiting |
NCT04683133 -
The FAST OCT Study
|
N/A | |
Withdrawn |
NCT00463853 -
Stem Cell Therapy as Adjunct to Revascularization
|
Phase 1 | |
Completed |
NCT00157716 -
MEND-CABG (MC-1 to Eliminate Necrosis and Damage in Coronary Artery Bypass Graft Surgery)
|
Phase 2 |